Participating Faculty: New Approaches to Measuring Value in Oncology Therapy

Supplements and Featured Publications, New Approaches to Measuring Value in Oncology Therapy, Volume 18, Issue 11 Suppl

This supplement to The American Journal of Managed Care reports the results of 4 studies analyzing novel aspects of the value generated by oncology agents. These 4 studies lay out new approaches to incorporating dynamic and patient-centered considerations into value and cost-effectiveness calculations. These findings may help managed care organizations better understand and quantify the value oncology therapies produce for patients with cancer.This supplement was supported by Bristol-Myers Squibb.

FacultyTheodore Darkow, PharmD

Director

Health Services

US Medical

Bristol-Myers Squibb

Plainsboro, New Jersey

Dana Goldman, PhD

Director

Leonard D. Schaeffer Center for Health Policy and Economics

Professor

Norman Topping Chair in Medicine and Public Policy

USC Sol Price School of Public Policy

School of Pharmacy

University of Southern California

Los Angeles, California

Geoffrey F. Joyce, PhD

Director of Health Policy

Leonard D. Schaeffer Center for Health Policy and Economics

Associate Professor

Pharmaceutical Economics and Policy

School of Pharmacy

University of Southern California

Los Angeles, California

Darius N. Lakdawalla, PhD

Director of Research

Leonard D. Schaeffer Center for Health Policy and Economics

Quintiles Professor of Pharmaceutical and Regulatory Innovation

School of Pharmacy

Sol Price School of Public Policy

University of Southern California

Los Angeles, California

Yang Lu, PhD

Assistant Professor of Research

Leonard D. Schaeffer Center for Health Policy and Economics

School of Medicine

University of Southern California

Los Angeles, California

J. Ross Maclean, MD

Vice President

Cardiovascular and Metabolics

Bristol-Myers Squibb

Plainsboro, New Jersey

John R. Penrod, PhD

Director

Health Services, Oncology

US Medical

Bristol-Myers Squibb

Plainsboro, New Jersey

Tomas Philipson, PhD

Daniel Levin Professor of Public Policy Studies

Harris Graduate School of Public Policy

University of Chicago

Chicago, Illinois

Xiaoli Lily Qiu, PhD

Analytic Consultant

Precision Health Economics

Los Angeles, California

John Romley, PhD

Research Assistant Professor

Leonard D. Schaeffer Center for Health Policy and Economics

Sol Price School of Public Policy

University of Southern California

Los Angeles, California

Yuri Sanchez, PhD

Research Economist

Precision Health Economics

Los Angeles, California

Julia Thornton Snider, PhD

Research Economist

Precision Health Economics

Los Angeles, California

Neeraj Sood, PhD

Director of International Programs

Leonard D. Schaeffer Center for Health Policy and Economics

Associate Professor

Pharmaceutical Economics and Policy

School of Pharmacy

University of Southern California

Los Angeles, California

Saarah Woodby, BA

Intern/Consultant

Bristol-Myers Squibb

Plainsboro, New Jersey

Wesley Yin, PhD

Assistant Professor

Department of Economics

Boston University

Boston, Massachusetts

Disclosures

These faculty report relationships with the following organizations:

Theodore Darkow, PharmD

Employee/stock ownership: Bristol-Myers Squibb

Dana Goldman, PhD

Consultant: Bristol-Myers Squibb

Partnership: Precision Health Economics

Geoffrey F. Joyce, PhD

Consultant: Precision Health Economics

Darius N. Lakdawalla, PhD

Consultant: Bristol-Myers Squibb

Partnership: Precision Health Economics

J. Ross Maclean, MD

Employee/stock ownership: Bristol-Myers Squibb

John R. Penrod, PhD

Employee/stock ownership: Bristol-Myers Squibb

Tomas Philipson, PhD

Consultant: Bristol-Myers Squibb

Partnership: Precision Health Economics

Xiaoli Lily Qiu, PhD

Consultant: Precision Health Economics

John Romley, PhD

Consultant: Precision Health Economics

Yuri Sanchez, PhD

Employee: Precision Health Economics

Julia Thornton Snider, PhD

Employee: Precision Health Economics

Neeraj Sood, PhD

Consultant: Precision Health Economics

Saarah Woodby, BA

Consultant: Bristol-Myers Squibb

Wesley Yin, PhD

Consultant: Precision Health Economics

Yang Lu, PhD, reports no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this supplement.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, the editorial staff, or any member of the editorial advisory board. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.